Last updated: July 19, 2024
Sponsor: Astra Zeneca
Overall Status: Active - Not Recruiting
Phase
3
Condition
Asthma
Treatment
N/AClinical Study ID
TX312817
D5982C00005
Ages 12-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
North Carolina Clinical Research- 919-881-0309 and ask for LITHOS Study Coordinator OR Visit our website at NCCR.com and complete the information for " Join a Study"
Dr. Craig LaForce and Dr. Karen Dunn, Board Certified in Allergy and Immunology
Study Design
Study Start date:
January 19, 2023
Estimated Completion Date:
Study Description
Connect with a study center
North Carolina Clinical Research
Raleigh, North Carolina 27607
United StatesActive - Not Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.